Trial Profile
Investigation of the safety and efficacy of Budesonide ( Zentacort Capsules ) in patients with Crohn's disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Zeria
- 23 Oct 2018 New trial record